Pediatric Department, Children's University hospital, Faculty of Medicine, Minia University, El-Minya, Egypt.
Clinical Pathology Department, Children's University hospital, Faculty of Medicine, Minia University, El-Minya, Egypt.
BMC Pediatr. 2020 Aug 19;20(1):387. doi: 10.1186/s12887-020-02278-4.
Sepsis is still one of the main causes of infants and children mortality especially in developing, economically challenged countries with limited resources. Our objective in this study was to determine, the prognostic value of platelet count, mean platelet volume (MPV), platelet distribution width (PDW) and plateletcrit (PCT) in critically ill infants and children with severe sepsis, as they are readily available biomarkers, that can guide clinicians during managing of severe sepsis.
Sixty children were included; they were diagnosed with severe sepsis according to the international pediatric sepsis consensus conference criteria. At admission to Pediatric intensive care unit, complete blood count with platelet count and parameters (MPV, PDW and PCT) and C-reactive protein (CRP) level were determined for all children. Also, assessment of the Pediatric Risk of Mortality (PRISM III) score was done to all. These children were followed up till discharge from hospital or death. Accordingly, they were grouped into: (1) Survivor group: included 41 children. (2) Non-survivor group: included 19 children.
Platelet count and PCT were significantly lower (p < 0.001) and MPV was significantly higher in non-survivor than survivors (p = 0.004). MPV/PLT, MPV/PCT, PDW/PLT, PDW/PCT ratios were found to be significantly higher in the non-survivors than survivor (p < 0.001 in all). PCT with sensitivity = 94.74%, was the most sensitive platelet parameter for prediction of death, while MPV/PCT was the most sensitive ratio (sensitivity = 94.7%).
Thrombocytopenia, platelet indices and their ratios, especially plateletcrit and MPV/PCT, are readily available, sensitive, prognostic markers, that can identify the severe sepsis patients with poorest outcome.
脓毒症仍然是婴儿和儿童死亡的主要原因之一,尤其是在资源有限的发展中经济困难国家。我们的研究目的是确定血小板计数、血小板平均体积(MPV)、血小板分布宽度(PDW)和血小板压积(PCT)在患有严重脓毒症的危重症婴儿和儿童中的预后价值,因为这些是易于获得的生物标志物,可以在严重脓毒症的管理中指导临床医生。
共纳入 60 名儿童;根据国际儿科脓毒症共识会议标准诊断为严重脓毒症。所有儿童入院入儿科重症监护病房时,均测定全血细胞计数和血小板计数及参数(MPV、PDW 和 PCT)和 C 反应蛋白(CRP)水平。此外,对所有儿童进行儿科死亡率风险评分(PRISM III)评估。这些儿童一直随访至出院或死亡。据此,将他们分为:(1)存活组:包括 41 名儿童。(2)非存活组:包括 19 名儿童。
非存活组血小板计数和 PCT 显著降低(p<0.001),MPV 显著高于存活组(p=0.004)。非存活组的 MPV/PLT、MPV/PCT、PDW/PLT、PDW/PCT 比值均显著高于存活组(p<0.001)。PCT 的灵敏度为 94.74%,是预测死亡的最敏感血小板参数,而 MPV/PCT 是最敏感的比值(灵敏度为 94.7%)。
血小板减少症、血小板指数及其比值,尤其是血小板压积和 MPV/PCT,是易于获得的、敏感的预后标志物,可以识别预后最差的严重脓毒症患者。